广东省乙型病毒性肝炎疫苗接种指引(试行)

doi:10.13217/j.scjpm.2013.01.092

Abstract

CLC Number:

R512.62

Guangdong Provincial Center for Disease Control and Prevention. Guidelines for hepatitis B vaccination in Guangdong Province (for trial implementation)[J].S China J Prev Med, 2013, 39(1): 92-93+97.

［1］World Health Organization Hepatitis B vaccines 2 October 2009.［EB/OL］. ［2011-05-02］.http://www.who.int/wer/2009/wer8440.pdf.
［2］卫生部疾病预防控制局，中国疾病预防控制中心. 全国人群乙型病毒性肝炎血清流行病学调查报告［M］. 北京：人民卫生出版社，2011：55.
［3］戴志澄, 祁国明.中国病毒性肝炎血清流行病学调查 (上卷) ［M ］.北京:科学技术出版社, 1997：39-47.
［4］彭国文，骆雄才，韩轲，等. 广东省实施新生儿乙肝疫苗接种后免疫效果评价［J］. 华南预防医学，2008，34（1）：10-12.
［5］梁剑，邵晓萍，吴承刚，等.广东省乙型病毒性肝炎表面抗原携带率的变化分析［J］. 华南预防医学，2011，37（4）：40-42.
［6］中华预防医学会，中国疾病预防控制中心免疫规划中心. 中国成人乙型肝炎免疫预防技术指南［J］. 中华流行病学杂志，2011，32（12）：1199-1203.
［7］中华医学会肝病学分会，中华医学会感染病学分会. 慢性乙型肝炎防治指南（2010年版）［J］. 中华临床感染病杂志，2011，4（1）：1-13.
［8］Ministry of Health, New Zealand. Immunization Handbook 2011 ［EB/OL］. ［2011-05-02］.http://www.health.govt.nz/publication/immunisationhandbook2011.
［9］孙莲英，庞志钊，张文英，等.不同剂量重组乙型肝炎疫苗( 酵母) 阻断乙型肝炎病毒母婴传播的研究［J］. 中国计划免疫，2006，12(4)：262-263.
［10］张丽，张卫，翟祥军，等.新生儿5 μg和 10 μg重组酵母乙型肝炎疫苗初免后抗体免疫应答比较［J］. 中华流行病学杂志，2012，33（3）：305-308.
［11］曾滢，李杰，宋雪芳，等.10微克/剂重组乙型肝炎疫苗（酿酒酵母）接种新生儿的安全性评价［J］. 中国计划免疫，2011，17(6)：506-509.
［12］梁争论 , 李艳萍 , 荆庆 , 等.一种新型重组( 汉逊酵母) 乙型肝炎疫苗人体安全性和免疫效果考核［J］. 中国计划免疫，2004，10(4)：193-197.
［13］张吉凯，郑慧贞，左兴，等.新生儿接种乙肝疫苗和乙肝免疫球蛋白免疫效果的分析［J］. 华南预防医学，2012，38（3）：33-36.
［14］[CM(73mm]ERIC E. MAST, HAROLD S. MARGOLIS, ANTHONY E. [CM)]
[CS0, 0, 0, 0]［1］[CS]FIORE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Recommendations of the advisory co

[1]	. [J]. South China Journal of Preventive Medicine, 2022, 48(10): 1264-1267.
[2]	. [J]. South China Journal of Preventive Medicine, 2022, 48(7): 851-853.
[3]	. [J]. South China Journal of Preventive Medicine, 2022, 48(5): 608-610.
[4]	LIU Min-huan, ZHANG Shi-xi, WANG Cai-xia. Serum inflammatory factor levels and disease progression in patients with chronic hepatitis B virus infection [J]. South China Journal of Preventive Medicine, 2022, 48(4): 438-442.
[5]	ZHOU Cong, CHEN Qiu-yun, LIU Miao-miao. Epidemiological characteristics of hepatitis B in Yangchun City, 2009-2013 [J]. S China J Prev Med, 2016, 42(1): 58-60.
[6]	TAN Qiu, WU Cheng-gang, LIANG Jian,SHAO Xiap-ping. Family aggregation and factor analysis of HBV infection in Guangdong Province [J]. S China J Prev Med, 2014, 40(5): 468-471.
[7]	ZHONG Gui-hong, LIU Yu, SHAO Xiao-ping, ZHENG Hui-zhen. Surveillance of adverse events following hepatitis B vaccine immunization in Guangdong Province, 2009-2012 [J]. S China J Prev Med, 2014, 40(4): 380-383.
[8]	LUO Tao, PAN Hong, HOU Xing-hua, DENG Mao-ming, WU Yun-feng, GUO Yu, DUAN Lin-li, WU Nian-biao, YANG Bin.. Evaluation of MOH/GAVI project for improving timely birth dose coverage of hepatitis B vaccination in Qiandongnan, Guizhou [J]. S China J Prev Med, 2014, 40(1): 25-28.
[9]	. [J]. S China J Prev Med, 2013, 39(5): 44-45.
[10]	ZHAN Liu-hua, ZHOU Wen, XIAO Xiao-ling, DAI Liping; REN Wei; WU Xin-wei; HE Jin-hong; LI Jie-han; WU Chu-xian; LIU Fang-hua; HAO Yuan-tao. Management of integrated prevention and control of hepatitis B in community by using residential electronic health records platform [J]. S China J Prev Med, 2013, 39(4): 88-90.
[11]	FU Zhi-zhi, LV Wei, XU Wu-zhe, REN Mei-xuan．. Epidemiological characteristics of hepatitis B in Guangxi, 2005-2012 [J]. S China J Prev Med, 2013, 39(4): 20-24.
[12]	. [J]. S China J Prev Med, 2013, 39(3): 77-79.
[13]	CAI Li, CAI Lin, DUAN Li-na, FANG Qiong, LIN Bao-ni, ZHOU Zhi-feng. Investigation on status of interrupting maternal-infant transmission of hepatitis B virus in Futian District, Shenzhen City, 2012 [J]. S China J Prev Med, 2013, 39(2): 45-47.
[14]	LI Jing, MAO Chong-shan, XIAO Er-hui, LIU Jun-ping, LU Xi-ling, PENG Zhen, LIU Cui-ping. Expression level and clinical significance of apoptosis molecules in peripheral blood mononuclear cells of patients with chronic hepatitis B [J]. South China Journal of Preventive Medicine, 2021, 47(10): 1267-1271.
[15]	HE Yan, ZHOU Yu-xia, YU Wu-bei, XU Qing-jie. Status of drug resistance in patients with chronic hepatitis B in Kaifeng City and gene mutation sites of common nucleoside （acid） drug resistance [J]. South China Journal of Preventive Medicine, 2022, 48(6): 660-664.

Guidelines for hepatitis B vaccination in Guangdong Province (for trial implementation)

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 0